Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK
The UK's COVID-19 epidemic during early 2020 was one of world's largest and unusually well represented by virus genomic sampling. Here we reveal the fine-scale genetic lineage structure of this epidemic through analysis of 50,887 SARS-CoV-2 genomes,...
13
Andrew Rambaut š¦ š§¬š²š®š¤¦āāļø
Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK:
medrxiv.org/content/10.110ā¦
gestated to term by @EvolveDotZoo and based on the @CovidGenomicsUK CoG-UK project data.
121d
1
Adam Kucharski
Great genomic analysis of early SARS-CoV-2 epidemic in the UK by @laduplessis @EvolveDotZoo @CovidGenomicsUK and co medrxiv.org/content/10.110ā¦ pic.twitter.com/lTbDgCwCB3
121d
Join the Lab - Cara E. Brook
27
Cara Brook
Excited to announce that my new lab at the University of Chicago is recruiting PhD students, postdocs, and field techs to study the ecology and evolution of zoonotic diseases, starting fall 2021! brooklab.org/jointhelab pic.twitter.com/FjCj4mUcUV
121d
WHO warns giving up on efforts to control Covid-19 would be 'dangerous'
White House Chief of Staff Mark Meadows seemed to indicate the Trump administration has concluded containment of the virus is not possible.
4
Tom Inglesby
.@WHO: 'The alternative [to working to contain COVID] is to face a ātsunami of casesā that will put the health and lives of health care workers in jeopardy and cripple health care systems, he said. āYou run out of capacity to cope.ā
121d
5
Dr Alexandra Phelan
Lockdowns are not inevitable but an emergency stop. Countries can avoid them with comprehensive test, trace, quarantine, isolate, support systems & public uptake of measures to reduce transmission, inc. masks & distancing.
"Giving up" is never an option.
122d
4
Helen Branswell
Do not give up on trying to control #Covid19, @WHO urges. Lockdowns can be avoided if governments support test, trace & then support people in quarantine and individuals play their part too. The alternative? "A tsunami of cases" that strain health care.
122d
Covid-19 expert Akiko Iwasaki fights a different virus: sexism in science
To know virologist Akiko Iwasaki is to know that she is passionate about combatting sexism, power imbalance, and toxic behavior in academia.
15
Prof. Akiko Iwasaki
OMG šš¼š
Thank you so much @statnews @scchak for writing this article about me. It is not just a story about me, but of the brave and brilliant people who I surround myself with. This is a story of every #womeninSTEM.
statnews.com/2020/10/27/akiā¦ via
121d
2
Natalie E. Dean, PhD
From this nice @statnews profile of Prof. Iwasaki @VirusesImmunity, I wish I had received this advice when I was pregnant and on the job market. Looking back, the anxiety I felt about how my pregnancy would be "perceived" was wasted energy.
statnews.com/2020/10/27/akiā¦ pic.twitter.com/4uAMbKHa5D
121d
1
Helen Branswell
"If we want to do the best science we can, we need a diverse set of people." āĀ star Yale immunologist @VirusesImmunity talks to @scchak about battling sexism & toxic behavior in academia.
121d
Why You Shouldnāt Worry About Studies Showing Waning Coronavirus Antibodies
Experts say itās normal for levels of antibodies to drop after clearing an infection, and that they represent just one arm of the immune response against a virus.
19
Apoorva Mandavilli
The headlines, all of a sudden, are everywhere. UK study showed antibodies to the coronavirus decline so we're all doomed. No immunity, no vaccines, no herd immunity.
People, we have enough real things to worry about. Do not worry about this. 1/x
121d
SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility
During the evolution of SARS-CoV-2 in humans a D614G substitution in the spike (S) protein emerged and became the predominant circulating variant (S-614G) of the COVID-19 pandemic. However, whether the increasing prevalence of the S-614G variant...
5
Volker Thiel
Online now: SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility
Thanks for the great collaborative effort @Loeffler_News @DewIvcp @CharafBenarafa #D614G
121d
1
Marion Koopmans
Yes, the transmissibility of SARS COV 2 has increased, based on animal work. ā¦@EuropeVeoā© could explain part of the difference between early containment success and current situation
121d
Quantifying SARS-CoV-2 spread in Switzerland based on genomic sequencing data
Pathogen genomes provide insights into their evolution and epidemic spread. We sequenced 1,439 SARS-CoV-2 genomes from Switzerland, representing 3-7% of all confirmed cases per week. Using these data, we demonstrate that no one lineage became...
8
Tanja Stadler
Insights into the evolution and epidemiology of SARS-CoV-2 in Switzerland until the end of August based on data from our nation-wide sequencing effort; a time period covering the first wave, low case numbers, and slow exponential growth over the summer medrxiv.org/cgi/content/shā¦ 1/2
121d
Coronavirus antibody prevalence falling in England, REACT study shows | Imperial News | Imperial College London
Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.
6
Helen Ward
As we report the latest findings from the REACT studies this week, Iād like to say a huge thank you to the hundred of thousands of people who have taken part. You make a major contribution to research - we couldnāt do this without you!
122d
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
SARS-CoV-2 has caused a global pandemic with millions infected and numerous fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here we report that the vast majority...
3
Florian Krammer
New paper out on SARS-CoV-2 antibody responses with Ania Wajnberg, @FatimaAmanat @Shirin_Strohm @VivianaSimonLab @DanielStadlb @DrDavidReich, Adolfo Firpo, Carlos Cordon-Cardo and the whole team.
120d
Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected anterior nasal swab versus professional-collected nasopharyngeal swab
Background: Two antigen-detecting rapid diagnostic tests (Ag-RDTs) are now approved through the WHO Emergency Use Listing procedure and can be performed at the point-of-care. However, both tests use nasopharyngeal (NP) swab samples. NP swab samples...
3
Michael Mina
New paper showing strong agreement between nasal (ie self collection) and nasopharyngeal swab on rapid test. This is an important finding since, in US, rapid tests currently authorized for nasopharyngeal swabs and thus need healthcare collections
1/
121d
Understanding 'aerosol transmission' could be key to controlling coronavirus | Julian Tang
We should still wash our hands, but growing evidence suggests one of the main ways Covid spreads is through the air, says clinical virologist Julian Tang
4
Linsey Marr
Excellent op-ed from someone who has studied airborne transmission of viruses for a long time: Julian Tang
121d
āEvery minute counts.ā This immunologist rapidly reshaped her lab to tackle COVID-19
For Akiko Iwasaki, the pandemic has brought new research prioritiesāand new urgency
5
Eric Topol
So great to see my friend @VirusesImmunity and her team's pandemic leading work @YaleIBIO @YaleMed @YaleEMD @YaleSPH getting this richly deserved recognition
sciencemag.org/news/2020/10/eā¦ @ScienceMagazine by @jcouzin
sciencemag.org/news/2020/10/eā¦ @statnews by @scchak pic.twitter.com/ywnKNow4Ob
121d
Covid-19 Live Updates: A Record-Breaking Week for U.S. Virus Cases
The country has averaged at least 71,000 new coronavirus cases a day over the past week, the most in any seven-day stretch of the pandemic.
2
Apoorva Mandavilli
NEW: New British report says antibody levels to coronavirus are declining, prompting widespread fears. But experts said these worries were overblown: āSome of these headlines are silly."
(Full story coming soon)
121d
Some Covid Survivors Have Antibodies That Attack the Body, not Virus
New research found āautoantibodiesā similar to those in lupus and rheumatoid arthritis patients. But patients may also benefit from treatments for those autoimmune diseases.
Research Data Analyst
Research Data Analyst
6
Elizabeth Lee
Join me, @andrewazman @JustinLessler @JHIDDynamics on research & implementation projects to inform @gavi, @SecGTFCC & @vaccineimpact on global #cholera vaccination guidance and #vaccine impact! Apply: jobs.jhu.edu/s/wU5arN
#appliedepi @IDDjobs @MIDAS_Network Please RT!
122d
Marking content as seen..
Subscribe to
Infectious Disease
